SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-041738
Filing Date
2024-05-10
Accepted
2024-05-10 16:18:59
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0205049-10q_therapeutics.htm   iXBRL 10-Q 466705
2 CERTIFICATION ea020504901ex31-1_therap.htm EX-31.1 9802
3 CERTIFICATION ea020504901ex31-2_therap.htm EX-31.2 10008
4 CERTIFICATION ea020504901ex32-1_therap.htm EX-32.1 4320
5 CERTIFICATION ea020504901ex32-2_therap.htm EX-32.2 4286
  Complete submission text file 0001213900-24-041738.txt   4006916

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE txmd-20240331.xsd EX-101.SCH 50075
7 XBRL CALCULATION FILE txmd-20240331_cal.xml EX-101.CAL 39505
8 XBRL DEFINITION FILE txmd-20240331_def.xml EX-101.DEF 220963
9 XBRL LABEL FILE txmd-20240331_lab.xml EX-101.LAB 396727
10 XBRL PRESENTATION FILE txmd-20240331_pre.xml EX-101.PRE 219768
69 EXTRACTED XBRL INSTANCE DOCUMENT ea0205049-10q_therapeutics_htm.xml XML 371065
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 24935192
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)